Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zaki Salanti"'
Autor:
Carsten F. Gotfredsen, Marianne O. Larsen, Zaki Salanti, Lotte Bjerre Knudsen, Anne-Marie Mølck, Inger Thorup, Niels C. Berg Nyborg
Publikováno v:
Diabetes. 63:2486-2497
Increased pancreas mass and glucagon-positive adenomas have been suggested to be a risk associated with sitagliptin or exenatide therapy in humans. Novo Nordisk has conducted extensive toxicology studies, including data on pancreas weight and histolo
Autor:
Peer Norbert Jørgensen, Christian Sommer, Jes Thorn Clausen, Zaki Salanti, Lisbeth Bjerring Jensen
Publikováno v:
Thrombosis and Haemostasis. 98:721-725
SummaryRecombinant activated factorVII (rFVIIa; NovoSeven®) has been widely used to treat bleeding in patients with haemophilia with inhibitors. To increase the intrinsic activity, analogues of rFVIIa (rFVIIaQ, rFVIIaDVQ, and rFVIIaDVQA) with altere